Aricept tablet 5 mg (donepezil hcl) — same day delivery. Donepezil hydrochloride is used for the palliative treatment of mild to moderate dementia of the Alzheimer's type Alzheimer's disease, ...

Donepezil (Demenza (5 mg)) is a cholinesterase inhibitor, prescribed for dementia of Alzheimer's disease. It works by increasing the amount of acetylcholine in the brain, which helps in improving ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Donepezil increases the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase. There is no evidence that donepezil alters the course of the underlying ...

NEW YORK (MedscapeWire) Apr 19 — Donepezil ( Aricept) isn't just for Alzheimer's anymore. Results of a randomized, placebo-controlled trial presented April 17 at the American Academy of Neurology 54th ...

Woodcliff Lake, NJ, and New York, July 23, 2010 - Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...

The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE) to produce guidance on using donepezil, galantamine, rivastigmine and memantine in the NHS in ...

City-based pharma major Dr Reddy’s Laboratories (DRL) on Saturday informed the bourses that it has launched Donepezil Hydrochloride tablets in the US market following the United States Food and Drug ...

September 6, 2012 — In a lawsuit filed Wednesday, the consumer advocacy group Public Citizen has asked the court to compel the US Food and Drug Administration (FDA) to act on its petition filed over a ...

Background A 78-year-old man with a 22-year history of schizoaffective disorder and a 5-year history of dementia presented to the emergency department with a 5-day history of fatigue, progressive ...

WOODCLIFF LAKE, N.J. & NEW YORK--(BUSINESS WIRE)-- Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...